Detalles de la búsqueda
1.
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852738
2.
Antibiotic therapy and outcome from immune-checkpoint inhibitors.
J Immunother Cancer
; 7(1): 287, 2019 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31694714
Resultados
1 -
2
de 2
1
Próxima >
>>